Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 134Lung Neoplasms 50Adenocarcinoma of Lung 18Adenocarcinoma, Bronchiolo-Alveolar 10Brain Neoplasms 9NSCLC 8Neoplasms 5Neoplasm Metastasis 5Adenocarcinoma 4Respiratory Tract Diseases 3Carcinoma 3Thoracic Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1Recurrence 1Previous Treated Metastatic Non-small Cell Lung Cancer 1Pleural Effusion, Malignant 1Parathyroid Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1

Interventions

Etoposide 156Carboplatin 146Cisplatin 106Topotecan 76durvalumab 53atezolizumab 51Irinotecan 45pembrolizumab 39Paclitaxel 35Nivolumab 33Radiotherapy 31PM 01183 26Drug Therapy 24anlotinib 23Gemcitabine 21apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Magnetic Resonance Spectroscopy 13Bevacizumab 13rovalpituzumab tesirine 11amrubicin 11Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Gefitinib × Thoracic × Clear all
NCT00298688 2008-06-12

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

AstraZeneca

Phase 2 Completed
56 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡